Important information on COVID-19
Vision Academy treatment recommendations for patients requiring intravitreal injections during COVID-19 have been published in Graefe’s Archive for Clinical and Experimental Ophthalmology. The open access article is available now, along with the Vision Academy’s Viewpoint article and educational slide deck.
In conjunction with the nAMD Barometer, the Vision Academy has also developed a customizable letter to patients. This letter, also published in Graefe’s Archive for Clinical and Experimental Ophthalmology as a Letter to the Editor, can be used by ophthalmologists to reassure and guide patients throughout the COVID-19 pandemic. Download the Vision Academy communication to healthcare professionals, the "Dear Patient" letter templates, and the patient guidance infographic here, and also view our short informational video below which you can share with your patients.
All of the following materials are available in multiple languages, downloadable from the All Resources section of this website.
Vision Academy members Jean-François Korobelnik, Anat Loewenstein, Paolo Lanzetta, and David Wong recently took part in a webinar to discuss the guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. You can listen to the discussion in the video below.
Click the buttons below to hear from Vision Academy members Dr. Monica Lövestam-Adrian and Professor Paolo Lanzetta in two special COVID-19 podcast episodes. Both episodes discuss the Vision Academy’s COVID-19 publication in Graefe's Archive for Clinical and Experimental Ophthalmology, with individual insights from both members.
Angiogenesis and COVID-19
Dr. William W. Li is the President, Medical Director, and co-founder of the Angiogenesis Foundation in the United States, whose recent work includes research into vascular effects and angiogenesis in COVID-19.
Watch Dr. Li’s presentation from the 2020 Vision Academy Annual Meeting for highlights from his research findings on angiogenesis and COVID-19.